Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT01777776 |
Title | Safety and Efficacy of LEE011 and LGX818 in Patients With BRAF Mutant Melanoma. |
Recruitment | Terminated |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | Yes |
Sponsors | Novartis Pharmaceuticals |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA | NLD | CAN | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Colorado Dept of Oncology | Aurora | Colorado | 80045 | United States | Details | |
Karmanos Cancer Institute Dept of Oncology | Detroit | Michigan | 48201 | United States | Details | |
Memorial Sloan Kettering Cancer Center Dept Oncology | NY | New York | 90033 | United States | Details | |
Oregon Health & Science University Dept. of OHSU (3) | Portland | Oregon | 97239 | United States | Details | |
Vanderbilt University Medical Center SC - Dept of Oncology . | Nashville | Tennessee | 37232 | United States | Details | |
Novartis Investigative Site | Westmead | New South Wales | 2145 | Australia | Details | |
Novartis Investigative Site | Woodville | South Australia | 5011 | Australia | Details | |
Novartis Investigative Site | Montreal | Quebec | H2X 3J4 | Canada | Details | |
Novartis Investigative Site | Utrecht | 3584CX | Netherlands | Details |